Balance Sheet
Cash Flow Statement
Daily Values
Growth Metrics
Income Statement
Others
Accumulated Depreciation & AmortizationEBIATLeasesLoans and Notes ReceivablesMachine, Furnitures, Fixtures & OtherNon-Current ReceivablesOther Gross PP&E AdjustmentsProperty, Plant & Equipment (Gross)Shares IssuedShares Outstanding
Ratios

Gyre Therapeutics (GYRE) Shares Outstanding: 2009-2025

Historic Shares Outstanding for Gyre Therapeutics (GYRE) over the last 10 years, with Sep 2025 value amounting to $90.9 million.

  • Gyre Therapeutics' Shares Outstanding rose 5.97% to $90.9 million in Q3 2025 from the same period last year, while for Sep 2025 it was $90.9 million, marking a year-over-year increase of 5.97%. This contributed to the annual value of $86.3 million for FY2024, which is 12.68% up from last year.
  • As of Q3 2025, Gyre Therapeutics' Shares Outstanding stood at $90.9 million, which was up 0.07% from $90.8 million recorded in Q2 2025.
  • In the past 5 years, Gyre Therapeutics' Shares Outstanding registered a high of $90.9 million during Q3 2025, and its lowest value of $31.3 million during Q1 2021.
  • In the last 3 years, Gyre Therapeutics' Shares Outstanding had a median value of $85.5 million in 2024 and averaged $80.0 million.
  • Data for Gyre Therapeutics' Shares Outstanding shows a peak YoY soared of 187.76% (in 2021) over the last 5 years.
  • Over the past 5 years, Gyre Therapeutics' Shares Outstanding (Quarterly) stood at $63.6 million in 2021, then remained steady at $63.6 million in 2022, then increased by 20.46% to $76.6 million in 2023, then rose by 12.68% to $86.3 million in 2024, then increased by 5.97% to $90.9 million in 2025.
  • Its last three reported values are $90.9 million in Q3 2025, $90.8 million for Q2 2025, and $87.6 million during Q1 2025.